These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 4673563

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Levodopa and adventitious movements.
    Lieberman AN, Pedersen B.
    Lancet; 1970 Nov 07; 2(7680):985. PubMed ID: 4097634
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ro 4-4602 and levodopa in the treatment of Parkinsonism.
    Miller EM, Wiener L.
    Neurology; 1974 May 07; 24(5):482-6. PubMed ID: 4857107
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Parkinsonism-dementia of Guam: treatment with levodopa and L-alpha-methyldopahydrazine.
    Holden EM, Brody JA, Chase TN.
    Neurology; 1974 Mar 07; 24(3):263-5. PubMed ID: 4855953
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK, Sonninen V, Siirtola T.
    Eur Neurol; 1973 Mar 07; 9(6):349-62. PubMed ID: 4712542
    [No Abstract] [Full Text] [Related]

  • 12. Long-term treatment of parkinsonism with levodopa.
    Boshes B.
    Postgrad Med; 1971 Dec 07; 50(6):94-9. PubMed ID: 5001838
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sustained-release levodopa in parkinsonism.
    Eckstein B, Shaw K, Stern G.
    Lancet; 1973 Feb 24; 1(7800):431-2. PubMed ID: 4119747
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
    Dupont E, Hansen E, Melsens S, Parkenberg H, Holm P.
    Acta Neurol Scand Suppl; 1972 Feb 24; 51():115-7. PubMed ID: 4514334
    [No Abstract] [Full Text] [Related]

  • 19. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders.
    Timberlake WH.
    Neurology; 1970 Dec 24; 20(12):31-5. PubMed ID: 4924342
    [No Abstract] [Full Text] [Related]

  • 20. Metabolism and clinical assessment of L-dopa in parkinsonism.
    Ericsson AD, McCann D, Sharpless N, Reveno W.
    Neurology; 1970 Apr 24; 20(4):402. PubMed ID: 4935027
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.